Alnylam Pharmaceuticals Inc. (ALNY) is priced at $208.49 after the most recent trading session. At the very opening of the session, the stock price was $209.99 and reached a high price of $214.67, prior to closing the session it reached the value of $209.41. The stock touched a low price of $207.46.Recently in News on November 9, 2022, Alnylam to Webcast Presentations at Upcoming November Investor Conferences. Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences:. You can read further details here
Alnylam Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $236.80 on 08/12/22, with the lowest value was $117.58 for the same time period, recorded on 05/12/22.
Alnylam Pharmaceuticals Inc. (ALNY) full year performance was 11.40%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Alnylam Pharmaceuticals Inc. shares are logging -11.96% during the 52-week period from high price, and 77.32% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $117.58 and $236.80.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 377444 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Alnylam Pharmaceuticals Inc. (ALNY) recorded performance in the market was 22.94%, having the revenues showcasing -2.54% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 24.68B, as it employees total of 1665 workers.
Alnylam Pharmaceuticals Inc. (ALNY) in the eye of market guru’s
During the last month, 15 analysts gave the Alnylam Pharmaceuticals Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 10 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 195.94, with a change in the price was noted +57.76. In a similar fashion, Alnylam Pharmaceuticals Inc. posted a movement of +38.32% for the period of last 100 days, recording 989,158 in trading volumes.
Alnylam Pharmaceuticals Inc. (ALNY): Stocks Technical analysis and Trends
Raw Stochastic average of Alnylam Pharmaceuticals Inc. in the period of last 50 days is set at 65.56%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 56.16%. In the last 20 days, the company’s Stochastic %K was 55.20% and its Stochastic %D was recorded 63.13%.
If we look into the earlier routines of Alnylam Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 22.94%. Additionally, trading for the stock in the period of the last six months notably improved by 64.49%, alongside a boost of 11.40% for the period of the last 12 months. The shares increased approximately by -1.65% in the 7-day charts and went down by 5.00% in the period of the last 30 days. Common stock shares were lifted by -2.54% during last recorded quarter.